Linagliptin (BI-1356) |cas 668270-12-0 |DC Chemicals|Supplier|Price|Buy

DC Chemicals Supply: Linagliptin (BI-1356) ,cas 668270-12-0, Cat No. DC1105, In stock

Contact: website:www.dcchemicals.com,

sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,

Tel: +86-21-61454686;Fax:+86-21-61642540；

Product name: Linagliptin (BI-1356), Synonym:　BI1356, BI 1356, Cat No. DC1105, Cas: 668270-12-0, Chemical Name:(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, Molecular Formula: C25H28N8O2, MW: 472.54

Linagliptin (BI-1356) Cas#668270-12-0.Purity:>98%.Best Price and Quality in the Market!Supplied by DC Chemicals! Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.

Description of Linagliptin: Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes.[1] It is being marketed by Boehringer Ingelheim and Lilly.

For the detailed information about the solubility of Linagliptin (BI-1356) in water, the solubility of Linagliptin (BI-1356) in DMSO, the solubility of Linagliptin (BI-1356) in PBS buffer, the animal experiment of Linagliptin (BI-1356),the in vivo and in vitro test of Linagliptin (BI-1356),the cell experiment of Linagliptin (BI-1356),the IC50 and EC50 of Linagliptin (BI-1356)please contact DC Chemicals.